NCT02436473

Brief Summary

The purpose of this study is to evaluate the effect of the test toothpaste containing 1150 parts per million (ppm) of fluoride (F) on the mineral content of demineralized enamel specimens, in an in situ caries model system, by comparing the differences in net remineralization change (ΔM) following use of the test toothpaste with a fluoride free (0 ppm F) reference control toothpaste.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Dec 2015

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 4, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 6, 2015

Completed
7 months until next milestone

Study Start

First participant enrolled

December 1, 2015

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2016

Completed
Last Updated

August 13, 2015

Status Verified

August 1, 2015

Enrollment Period

11 months

First QC Date

May 4, 2015

Last Update Submit

August 10, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • Net remineralization change (ΔM) of demineralised enamel specimens following use of the test toothpaste with a fluoride free reference control toothpaste

    The change in mineral content (ΔM) of the lesions as measured by Transverse Microradiography (TMR) will be calculated by the following formula: ΔM= (Post-treatment ΔZ - baseline ΔZ)

    4 weeks

Secondary Outcomes (3)

  • Net remineralization change (ΔM) of demineralised enamel specimens following use of the test toothpaste with all other treatments

    4 weeks

  • Changes in enamel lesion depth (ΔL) following use of the test toothpaste with all other treatments

    4 weeks

  • Net change in surface zone mineral content (ΔSZmax) following use of the toothpaste with all other treatments

    4 weeks

Study Arms (4)

Test fluoride toothpaste

EXPERIMENTAL

Participants will apply 1.5 weighed g (± 0.1 g) of the study toothpaste to a wet toothbrush and brush their natural teeth twice daily for one timed minute. Participants will wear their mandibular partial denture with test specimens while brushing and continuously for 24 hours a day during each of the 4-week treatment periods

Drug: Toothpaste containing 1150ppm F

Fluoride free (0ppm F) reference control toothpaste

PLACEBO COMPARATOR

Participants will apply 1.5 weighed g (± 0.1 g) of the study toothpaste to a wet toothbrush and brush their natural teeth twice daily for one timed minute. Participants will wear their mandibular partial denture with test specimens while brushing and continuously for 24 hours a day during each of the 4-week treatment periods.

Other: Toothpaste containing 0ppm F

Low dose fluoride (250ppm F) reference control toothpaste

ACTIVE COMPARATOR

Participants will apply 1.5 weighed g (± 0.1 g) of the study toothpaste to a wet toothbrush and brush their natural teeth twice daily for one timed minute. Participants will wear their mandibular partial denture with test specimens while brushing and continuously for 24 hours a day during each of the 4-week treatment periods.

Drug: Toothpaste containing 250ppm F

Fluoride (1150ppm F) reference control toothpaste

ACTIVE COMPARATOR

Participants will apply 1.5 weighed g (± 0.1 g) of the study toothpaste to a wet toothbrush and brush their natural teeth twice daily for one timed minute. Participants will wear their mandibular partial denture with test specimens while brushing and continuously for 24 hours a day during each of the 4-week treatment periods.

Drug: Toothpaste containing 1150ppm F

Interventions

US marketed toothpaste containing 1150ppm of F

Test fluoride toothpaste

Experimental toothpaste containing 0ppm F

Fluoride free (0ppm F) reference control toothpaste

Experimental toothpaste containing 250ppm F

Low dose fluoride (250ppm F) reference control toothpaste

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Demonstrates understanding of the study.
  • Aged 18 to 85 years.
  • Understands and is willing, able and likely to comply with all study procedures and restrictions.
  • Has good general health (in the opinion of the investigator or medically qualified designee).
  • Currently living in the Indianapolis, Indiana area.
  • Currently wearing a removable mandibular partial denture with sufficient room in the posterior buccal flange area to accommodate two enamel specimens.
  • Have no current active caries or periodontal disease and all restorations in a good state of repair.
  • Have a salivary flow rate in the range of normal values.

You may not qualify if:

  • Pregnant or breast feeding women.
  • Known or suspected intolerance or hypersensitivity to the study materials or their stated ingredients.
  • Currently taking antibiotics or have taken antibiotics in the two weeks prior to the screening visit.
  • Unable to measure product weights accurately using the assigned study scale as determined by the study staff as demonstrated.
  • Participation in another clinical study or receipt of an investigational drug within 30 days of the screening visit.
  • Have received a professional fluoride treatment within 14 days of randomization to the first treatment.
  • Recent history (within the last year) of alcohol or other substance abuse.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Dental Caries

Condition Hierarchy (Ancestors)

Tooth DemineralizationTooth DiseasesStomatognathic Diseases

Study Officials

  • GSK Clinical Trials

    GlaxoSmithKline

    STUDY DIRECTOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 4, 2015

First Posted

May 6, 2015

Study Start

December 1, 2015

Primary Completion

November 1, 2016

Study Completion

November 1, 2016

Last Updated

August 13, 2015

Record last verified: 2015-08